What price target do analysts set for Quest Diagnostics'stock?
What price target have analysts set for DGX? 10 Wall Street analysts have issued 1-year price objectives for Quest Diagnostics' shares. Their forecasts range from $137.00 to $181.00. On average, they anticipate Quest Diagnostics' stock price to reach $160.70 in the next year. This suggests that the stock has a possible downside of 4.6%.
What is the ticker symbol for Quest Diagnostics?
Quest Diagnostics trades on the New York Stock Exchange (NYSE) under the ticker symbol "DGX." Who are Quest Diagnostics' major shareholders? Quest Diagnostics' stock is owned by many different institutional and retail investors.
Is Quest Diagnostics'downside down 4% from current price?
According to analysts' consensus price target of $160.70, Quest Diagnostics has a forecasted downside of 4.7% from its current price of $168.61. Quest Diagnostics has only been the subject of 3 research reports in the past 90 days. Quest Diagnostics has received 497 “outperform” votes. (Add your “outperform” vote.)
Who are Quest Diagnostics'(DGX) competitors?
Some companies that are related to Quest Diagnostics include Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), AMN Healthcare Services (AMN), Amedisys (AMED), LHC Group (LHCG), CorVel (CRVL), MEDNAX (MD), Tivity Health (TVTY) and Cross Country Healthcare (CCRN). View all of DGX's competitors.
See more
Is Quest Diagnostics publicly traded?
Quest Diagnostics is an American clinical laboratory....Quest Diagnostics.TypePublic companyTraded asNYSE: DGX S&P 500 componentIndustryHealth careFounded1967 in New York City, United StatesFounderPaul Brown12 more rows
Is Quest Diagnostics stock a good buy?
We believe that Quest will benefit over the next year from its new coronavirus tests, increased demand for testing services, and strong cost controls. As such, our rating remains BUY with a target price of $135.
Who owns Quest diagnostic?
Paul Brown founded Quest in 1967 out of a single-room Manhattan apartment—with a $500 loan from his father-in-law to start the company, he used his bathtub as a staining area for Pap test slides for cervical cancer, and his wife would drive specimens around town with their kids in the backseat.
How much market share does Quest Diagnostics have?
DGX's vs. Market share relative to its competitors, as of Q1 2022COMPANY NAMETICKERMARKET SHARE MRQ Q1 2022Quest Diagnostics IncDGX40.10 %Laboratory Corporation Of America HoldingsLH59.90%SUBTOTAL100%Apr 30, 2022
Who is bigger quest or LabCorp?
For years, Quest was the largest, but LabCorp took over that spot a few years ago. Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp. Since 2008, LabCorp has acquired 19 companies.
Is Quest Diagnostics a Fortune 500 company?
Quest Marks 16 Years on Fortune 500 | Quest Diagnostics.
When did Quest Diagnostics go public?
1997(MetPath) in a two-bedroom apartment in Manhattan to provide better lab testing to area hospitals. Corning Glass Works acquired the company in 1982, grew the business through hundreds of acquisitions and later spun it off as a publicly traded company under the name Quest Diagnostics, at the beginning of 1997.
Is Quest Diagnostics a non profit organization?
Charitable Organization | EIN: 22-3093807 | Secaucus NJ The Quest Diagnostics Foundation Inc. is a 501(c)(3) organization, with an IRS ruling year of 1991, and donations are tax-deductible.
How many employees does Quest Diagnostics have?
Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
What is Quest Diagnostics known for?
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
When will quest diagnostics repurchase stock?
What is quest diagnostics?
Quest Diagnostics declared that its Board of Directors has approved a stock repurchase plan on Thursday, February 4th 2021, which allows the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 6.1% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board believes its stock is undervalued.
What is the dividend payout ratio of quest diagnostics?
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
What is the DGX symbol?
Quest Diagnostics does not yet have a strong track record of dividend growth. The dividend payout ratio of Quest Diagnostics is 22.18%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Quest Diagnostics will have a dividend payout ratio of 31.04% next year.
What is the official website for quest diagnostics?
Quest Diagnostics trades on the New York Stock Exchange (NYSE) under the ticker symbol "DGX."
What is the P/E ratio of quest diagnostics?
The official website for Quest Diagnostics is www.questdiagnostics.com.
What is Marketbeat community ratings?
The P/E ratio of Quest Diagnostics is 9.31 , which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.40.
How often do exchanges report short interest?
MarketBeat's community ratings are surveys of what our community members think about Quest Diagnostics and other stocks. Vote “Outperform” if you believe DGX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
How to calculate restricted stock?
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
How long are futures trading delayed?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
New York Stock Exchange
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
Environmental, Social, and Governance Rating
A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
